Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-06-14 Sale | 2024-06-18 9:39 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 1,900 | $280 | $532,000 | 15,850 (Direct) | View |
| 2024-06-12 Sale | 2024-06-14 9:44 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 2,000 | $285 | $570,000 | 20,700 (Direct) | View |
| 2024-05-21 Sale | 2024-05-23 9:36 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 1,036 | $231.34 | $239,668 | 5,500 (Direct) | View |
| 2024-05-14 Sale | 2024-05-16 9:53 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director | 22,489 | $212.88 | $4,787,404 | 489,685 (Indirect Direct) | View |
| 2024-04-08 Sale | 2024-04-10 8:53 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 2,676 | $245.99 | $658,258 | 1,191,103 (Indirect Direct) | View |
| 2024-04-08 Sale | 2024-04-10 8:50 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director | 26,270 | $246.19 | $6,467,491 | 1,047,531 (Indirect Direct) | View |
| 2024-04-03 Sale | 2024-04-05 8:50 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 73,888 | $243.92 | $18,022,588 | 1,425,808 (Indirect Direct) | View |
| 2024-04-03 Sale | 2024-04-05 8:50 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director | 73,730 | $243.93 | $17,984,804 | 1,612,789 (Indirect Direct) | View |
| 2024-04-01 Sale | 2024-04-03 8:47 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director | 11,000 | $257.48 | $2,832,335 | 25,298 (Direct) | View |
| 2024-04-01 Sale | 2024-04-03 8:44 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 32,489 | $252.85 | $8,214,998 | 22,410 (Direct) | View |
| 2024-04-01 Sale | 2024-04-03 8:41 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Daly James M Director | 32,489 | $252.97 | $8,218,630 | 12,110 (Direct) | View |
| 2023-12-14 Sale | 2023-12-18 4:30 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 4,000 | $235.5 | $942,000 | 42,067 (Direct) | View |
| 2023-12-13 Purchase | 2023-12-14 6:10 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director | 101,792 | $221.2 | $22,516,577 | 1,793,403 (Indirect) | View |
| 2023-12-12 Purchase | 2023-12-14 6:09 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director | 34,578 | $218.31 | $7,548,616 | 1,699,129 (Indirect) | View |
| 2023-12-12 Sale | 2023-12-14 4:30 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 3,800 | $222.82 | $846,700 | 50,567 (Direct) | View |
| 2023-12-04 Sale | 2023-12-06 4:30 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Lynch Brian Joseph SVP and General Counsel | 2,800 | $221.89 | $621,294 | 122,731 (Indirect Direct) | View |
| 2023-11-29 Sale | 2023-12-01 4:30 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Lynch Brian Joseph SVP and General Counsel | 7,000 | $201.5 | $1,410,480 | 54,531 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-25 Option Award | 2024-06-27 9:46 pm | N/A 2031-06-25 | MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director | 1,819 | $0 | 406,652 (Direct) | View |
| 2024-06-25 Option Award | 2024-06-27 9:45 pm | N/A 2031-06-25 | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 1,819 | $0 | 3,017 (Direct) | View |
| 2024-06-25 Option Award | 2024-06-27 9:42 pm | N/A 2031-06-25 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Daly James M Director | 1,819 | $0 | 3,017 (Direct) | View |
| 2024-06-25 Option Award | 2024-06-27 9:42 pm | N/A 2031-06-25 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director | 1,819 | $0 | 12,117 (Direct) | View |
| 2024-06-25 Option Award | 2024-06-27 9:41 pm | N/A 2031-06-25 | MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director | 1,819 | $0 | 843,094 (Direct) | View |
| 2024-06-25 Option Award | 2024-06-27 5:03 pm | N/A 2031-06-25 | MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 5,848 | $0 | 1,799,251 (Indirect) | View |
| 2024-06-14 Exercise | 2024-06-18 9:39 pm | N/A 2032-02-24 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 1,900 | $0 | 15,850 (Direct) | View |
| 2024-06-14 Exercise | 2024-06-18 9:39 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 1,900 | $87.09 | 15,850 (Direct) | View |
| 2024-06-12 Exercise | 2024-06-14 9:44 pm | N/A 2031-08-02 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 2,000 | $0 | 20,700 (Direct) | View |
| 2024-06-12 Exercise | 2024-06-14 9:44 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 2,000 | $87.92 | 20,700 (Direct) | View |
| 2024-06-11 Gift | 2024-06-13 9:45 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director | 84,852 | $0 | 404,833 (Direct) | View |
| 2024-05-14 Exercise | 2024-05-16 9:53 pm | N/A 2024-06-27 | MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director | 22,489 | $0 | 489,685 (Direct) | View |
| 2024-05-14 Exercise | 2024-05-16 9:53 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director | 12,489 | $105.08 | 489,685 (Direct) | View |
| 2024-05-14 Exercise | 2024-05-16 9:53 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director | 10,000 | $100.45 | 489,685 (Direct) | View |
| 2024-04-08 Exercise | 2024-04-10 8:53 pm | N/A 2026-07-22 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 2,676 | $0 | 1,191,103 (Direct) | View |
| 2024-04-08 Exercise | 2024-04-10 8:53 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 2,676 | $9.45 | 1,191,103 (Direct) | View |
| 2024-04-08 Exercise | 2024-04-10 8:50 pm | N/A 2026-07-22 | MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director | 26,270 | $0 | 1,047,531 (Direct) | View |
| 2024-04-08 Exercise | 2024-04-10 8:50 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director | 26,270 | $9.45 | 1,047,531 (Direct) | View |
| 2024-04-03 Exercise | 2024-04-05 8:50 pm | N/A 2026-07-22 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 73,888 | $0 | 1,425,808 (Direct) | View |
| 2024-04-03 Exercise | 2024-04-05 8:50 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 73,888 | $9.45 | 1,425,808 (Direct) | View |
| 2024-04-03 Exercise | 2024-04-05 8:50 pm | N/A 2026-07-22 | MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director | 73,730 | $0 | 1,612,789 (Direct) | View |
| 2024-04-03 Exercise | 2024-04-05 8:50 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director | 73,730 | $9.45 | 1,612,789 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 8:47 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director | 5,000 | $7.36 | 25,298 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 8:47 pm | N/A 2026-08-11 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director | 11,000 | $0 | 25,298 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 8:47 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director | 6,000 | $111.06 | 25,298 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 8:44 pm | N/A 2026-07-22 | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 32,489 | $0 | 22,410 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 8:44 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 12,489 | $105.08 | 22,410 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 8:44 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 10,000 | $9.45 | 22,410 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 8:44 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 10,000 | $100.45 | 22,410 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 8:41 pm | N/A 2024-06-27 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Daly James M Director | 32,489 | $0 | 12,110 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 8:41 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Daly James M Director | 12,489 | $105.08 | 12,110 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 8:41 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Daly James M Director | 20,000 | $100.45 | 12,110 (Direct) | View |
Ownership | 2024-03-21 4:30 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Dier Mardi SVP and CFO | 0 | $0 | 31,103 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 6:04 pm | N/A 2031-01-23 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Huntsman Carole Chief Commercial Officer | 9,122 | $0 | 20,595 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 5:54 pm | N/A 2031-01-23 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 14,504 | $0 | 1,129,043 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 5:50 pm | N/A 2031-01-23 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 3,557 | $0 | 10,093 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 3:29 pm | N/A 2031-01-23 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Howarth Alex G. Chief Financial Officer | 12,041 | $0 | 30,778 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 3:24 pm | N/A 2031-01-23 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Lynch Brian Joseph SVP and General Counsel | 9,122 | $0 | 27,343 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 3:24 pm | N/A 2031-01-23 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Sibold William John President and CEO | 30,709 | $0 | 92,959 (Direct) | View |
| 2024-01-16 Tax Withholding | 2024-01-18 1:52 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Lynch Brian Joseph SVP and General Counsel | 949 | $243.92 | 14,582 (Direct) | View |
| 2023-01-16 Tax Withholding | 2024-01-18 1:47 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director | 2,254 | $243.92 | 841,275 (Direct) | View |
| 2024-01-16 Tax Withholding | 2024-01-18 1:46 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 1,546 | $243.92 | 1,108,753 (Direct) | View |
| 2024-01-16 Tax Withholding | 2024-01-18 1:45 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 550 | $243.92 | 5,117 (Direct) | View |
| 2024-01-16 Tax Withholding | 2024-01-18 1:39 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Howarth Alex G. Chief Financial Officer | 1,067 | $243.92 | 13,934 (Direct) | View |
| 2023-12-14 Exercise | 2023-12-18 4:30 pm | N/A 2031-08-02 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 4,000 | $0 | 42,067 (Direct) | View |
| 2023-12-14 Exercise | 2023-12-18 4:30 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 4,000 | $87.92 | 42,067 (Direct) | View |
| 2023-12-12 Exercise | 2023-12-14 4:30 pm | N/A 2031-08-02 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 3,800 | $0 | 50,567 (Direct) | View |
| 2023-12-12 Exercise | 2023-12-14 4:30 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 3,800 | $87.92 | 50,567 (Direct) | View |
| 2023-12-07 Other | 2023-12-11 7:25 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director | 1,556,594 | $0 | 2,045,018 (Indirect) | View |
| 2023-01-30 Gift | 2023-12-11 7:25 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director | 3,557 | $0 | 2,045,018 (Indirect) | View |
| 2023-12-04 Exercise | 2023-12-06 4:30 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Lynch Brian Joseph SVP and General Counsel | 800 | $73.75 | 122,731 (Direct) | View |
| 2023-12-04 Exercise | 2023-12-06 4:30 pm | N/A 2032-08-10 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Lynch Brian Joseph SVP and General Counsel | 2,800 | $0 | 122,731 (Direct) | View |
| 2023-12-04 Exercise | 2023-12-06 4:30 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Lynch Brian Joseph SVP and General Counsel | 2,000 | $87.09 | 122,731 (Direct) | View |
| 2023-11-29 Exercise | 2023-12-01 4:30 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Lynch Brian Joseph SVP and General Counsel | 7,000 | $73.75 | 54,531 (Direct) | View |
| 2023-11-29 Exercise | 2023-12-01 4:30 pm | N/A 2032-08-10 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Lynch Brian Joseph SVP and General Counsel | 7,000 | $0 | 54,531 (Direct) | View |
| 2023-11-20 Option Award | 2023-11-22 5:02 pm | N/A 2033-11-20 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Huntsman Carole Chief Commercial Officer | 17,911 | $0 | 17,911 (Direct) | View |